SLC5A2 and metabolic disease: Therefore, in this study, we conducted a meta-analysis of randomized controlled trials (RCTs) to systematically evaluate the effects of SGLT2 inhibitors on LFC in adults with metabolic disorders, using MRI-based assessments.